Integrative Analysis of Glycosylation-Related Genes Reveals Prognostic Subtypes, Immune Evasion, and Therapeutic Vulnerabilities in Lung Adenocarcinoma

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2026 Open access

Read full text
Authors: Yu-Wei Liu, Yung‐Kuo Lee, Kai‐Fu Chang, Chung-Bao Hsieh, Chih-Hsuan Chang, Ching-Chung Ko, Hui-Ru Lin, Chi-Jen Wu, Chien-Han Yuan, Sachin Kumar, Damtew Solomon, Do Thi Minh Xuan
+6 more Neethu Palekkode, Ayman Fathima, Hung‐Yun Lin, Chih-Yang Wang, Chih‐Jen Yang, Yuen-Jung Wu
DOI: 10.32604/or.2026.074013
Cited by: 1

Abstract

GRG-based molecular stratification identifies clinically distinct LUAD subtypes associated with immune regulation, tumor stemness, and therapeutic response. The Glyco. marker system provides a potential framework for prognostic assessment and precision oncology strategies in LUAD.

Fields of Study & Subjects

Glycosylation and Glycoproteins Research Immune cells in cancer Immunotherapy and Immune Responses

Publication details

Journal / source
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Publisher
Tech Science Press
Volume
34
Issue
7
Pages
1–10
Publication date
1 January 2026
Language
EN